Medtronic (MDT) Tops Q1 EPS by 9c, Raises EPS Guidance

Medtronic (NYSE: MDT) reported Q1 EPS of $1.41, $0.09 better than the analyst estimate of $1.32. Revenue for the quarter came in at $7.99 billion versus the consensus estimate of $7.85 billion.

GUIDANCE:

Medtronic sees FY2022 EPS of $5.65-$5.75, versus the consensus of $5.69.

• company continues to expect revenue growth in its fiscal year 2022 to approximate 9% on an organic basis

For earnings history and earnings-related data on Medtronic (MDT) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Worthington Enterprises raises dividend 5%, adds board member
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth